Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18 Colonic Neoplasms 7 Rectal Neoplasms 5 Neoplasm Metastasis 5 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Unresectable Metastatic Colorectal Cancer 2 Ovarian Neoplasms 2 Gastrointestinal Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Solid Tumors 1 Prostatic Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Locally-advanced Rectal Cancer 1 Gastroesophageal Adenocarcinoma 1 Endometrial Neoplasms 1 Colorectal Cancer Metastatic 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

Nivolumab 2 Ipilimumab 2 glucopyranosyl lipid-A 1 Maraviroc 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Cancer Metastatic × Folfox protocol × Clear all

NCT03982121 2020-02-17

ISILI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡